← FDA Drug Approvals (Drugs@FDA)

ERYTHROMYCIN ETHYLSUCCINATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA USA · Approved 1988-09-14

Drug application

FDA Application #

ANDA062847

Application type

Abbreviated New Drug Application (Generic)

Brand name

ERYTHROMYCIN ETHYLSUCCINATE

Generic name

Erythromycin Ethylsuccinate

Active ingredients

ERYTHROMYCIN ETHYLSUCCINATE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

AUROBINDO PHARMA USA

First approval

1988-09-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown